Latest Neuroblastoma Stories
Patients with a high degree of African ancestry had a greater incidence of high-risk neuroblastoma and poorer outcomes.
A new treatment option may soon be available for children with neuroblastoma.
VIENNA, June 22, 2011 /PRNewswire/ -- Vienna based biotech company APEIRON Biologics AG (Apeiron) strengthens its oncology pipeline: The company will support the clinical development of an immune therapy against high-risk neuroblastoma that is being conducted by the Children's Cancer Research Institute (CCRI) and the European Neuroblastoma Research Network (SIOPEN).
Two Baylor College of Medicine doctors have received support for their research from Alex's Lemonade Stand, a nonprofit group dedicated to fighting pediatric cancer.
PHILADELPHIA, June 8, 2011 /PRNewswire-USNewswire/ -- Soupy for Loopy Foundation donated $50,000 to the Cancer Center at The Children's Hospital of Philadelphia to fund research in neuroblastoma, a childhood cancer of the nervous system.
GRAND RAPIDS, Mich., May 31, 2011 /PRNewswire/ -- The Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) today announced the opening of a first-of-its-kind genomic-based clinical trial to treat and study pediatric cancer - specifically relapsed and refractory neuroblastoma.
--The Cancer Center at Children's Hospital Pays Tribute to Longstanding Partnership During a Recognition Event -- PHILADELPHIA, May 11, 2011 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia announced today that it had received a $2 million gift awarded by Alex's Lemonade Stand Foundation (ALSF) as part of a longstanding partnership to eradicate pediatric cancer.
- A transitional zone between two communities containing the characteristic species of each.